Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression
Cancers | Free Full-Text | The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis | HTML
Types of Multiple Myeloma | International Myeloma Foundation
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Kappa Light Chain Antibody (HP6053 + L1C1) (NBP2-34258): Novus Biologicals
2-Methoxyestradiol at low dose induces differentiation of myeloma cells
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients - Experimental Hematology
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chron
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
Goat anti-Human Lambda Light Chain Secondary Antibody (NBP1-72788): Novus Biologicals